The pharmaceutical landscape is witnessing a shift with the introduction of GLP-1 transdermal systems . These cutting-edge formulations offer a possible alternative to delivering glucagon-like peptide-1 https://geraldfukj858492.mpeblog.com/73854561/glp-1-patches-a-novel-way-to-treat-blood-sugar